A Mu ltista ge, On e-P ot P r oced u r e Med ia ted by a Sin gle Ca ta lyst:
A New Ap p r oa ch to th e Ca ta lytic Asym m etr ic Syn th esis of
â-Am in o Acid s
Ahmed M. Hafez, Travis Dudding, Ty R. Wagerle, Meha H. Shah, Andrew E. Taggi, and
Thomas Lectka*
Department of Chemistry, J ohns Hopkins University, 3400 North Charles Street,
Baltimore, Maryland 21218
lectka@jhu.edu
Received February 3, 2003
A catalytic asymmetric procedure for the preparation of â-amino acids (specifically â-substituted
aspartic acid derivatives) is reported. The cinchona alkaloid catalyst benzoylquinine (BQ) mediates
up to five distinct steps of a reaction pathway, all in one reaction vessel. The products of this reaction,
highly optically enriched â-substituted aspartic acid derivatives, were prepared from N-acyl-R-
chloroglycine esters and acid chlorides in the presence of the catalyst. This approach was also
amenable to the synthesis of small polypeptides containing â-substituted aspartic acid units,
including a non-natural fragment of the antibiotic lysobactin. The addition of Lewis acids to this
system was found to accelerate the rate of specific steps in the reaction pathway. Mechanistic aspects
of this reaction, such as imine formation and Lewis acid chelation to the â-lactam intermediate,
were investigated through comparison of IR, NMR, and other physical data.
In tr od u ction
ties.5 To date, there are several preparative methods for
the catalytic asymmetric synthesis of â-amino acids.6
J acobsen7 and Miller8 have exploited the sequential
azidation/reduction of R,â-unsaturated carbonyl com-
pounds to this end. A different approach recently reported
by Boger utilizes the Sharpless asymmetric amino hy-
droxylation of cinnamate esters.9
In this paper, we discuss results that have broadened
the overall scope of our procedure for â-amino acid
synthesis.10 A noteworthy aspect of this approach in-
cludes the use of the organic catalyst benzoylquinine (BQ)
that is capable of performing multiple catalytic roles in
a single reaction flask. This catalyst carries out a series
of chemical transformations, in essence a pathway of
reactions. This method relies on the use of readily
available and stable reagents to produce optically en-
riched â-lactams or â-substituted aspartic acid deriva-
tives. We also examine mechanistic aspects of this
reaction with the study of N-acylimine formation from
R-chloroglycine derivatives and Lewis acid chelation to
Enzymes represent some of the most sophisticated and
elegant machinery known for carrying out selective and
highly specific chemical reactions. However, concurrent
with this specificity comes the associated cost of complex-
ity that can severely hamper their broader use as organic
reagents. The use of small organic molecules as highly
effective catalysts is being realized more frequently in
organic synthesis.1 However, a fundamental limitation
prevalent with the use of small organic catalysts is that
they usually perform only one chemical transformation
in the overall reaction sequence. From a synthetic
standpoint, it would be ideal if a single catalyst were
capable of mediating a series of reactions in one reaction
vessel. A biological analogy to such a process would be
the use of a single enzyme (or enzyme complex) to carry
out multiple steps in a biochemical pathway.
Substituted aspartic acid derivatives are currently of
interest medicinally for use as inhibitors of L-asparagine
synthetase,2 key constituents of several proteins involved
in the blood-clotting cascade,3 and for their ability to act
as nontransportable glutamate transporter blockers.4
Additionally, â-amino acids are also used as R-amino acid
surrogates for the construction of peptides possessing
interesting folding patterns and conformational proper-
(5) North, M. J . Peptide Sci. 2000, 6, 301-313.
(6) (a) Enantioselective Synthesis of â-Amino Acids; J uaristi, E., Ed.;
Wiley-VCH: New York, 1997. (b) Rzasa, R. M.; Shea, H. A.; Romo, D.
J . Am. Chem. Soc. 1998, 120, 591-592. (c) Cole, D. C. Tetrahedron
1994, 50, 9517-9582. (d) Kobayashi, S.; Nagayama, S. J . Am. Chem.
Soc. 1997, 119, 10049-10053. (e) Ferraris, D.; Young, B.; Dudding,
T.; Lectka, T. J . Am. Chem. Soc. 1998, 120, 4548-4549. (f) Sibi, M. P.;
Shay, J . J .; Liu, M.; J asperse, C. P. J . Am. Chem. Soc. 1998, 120, 6615-
6616. (g) Liu, M.; Sibi, M. P. Tetrahedron 2002, 58, 7991-8035.
(7) Myers, J . K.; J acobsen, E. N. J . Am. Chem. Soc. 1999, 121, 8959-
8960.
(1) For a comprehensive review, see: Dalko, P. I.; Moisan, L. Angew.
Chem., Int. Ed. 2001, 40, 3726-3748.
(2) Mokotoff, M.; Bagaglio, J . F.; Parikh, B. S. J . Med. Chem. 1975,
18, 354-358.
(3) (a) Hansson, T. G.; Kihlberg, J . O. J . Org. Chem. 1986, 51, 4490-
4492. (b) Wagner, R.; Tilley, J . W. J . Org. Chem. 1990, 55, 6289-6291.
(c) Wagner, R.; Tilley, J . W.; Lovey, K. Synthesis 1990, 785-786.
(4) Shimamoto, K.; Shigeri, Y.; Yasuda-Kamatani, Y.; Lebrun, B.;
Yumoto, N.; Nakajima, T. Bioorg. Med. Chem. Lett. 2000, 10, 2407-
2410.
(8) (a) Horstmann, T. E.; Guerin, D. J .; Miller, S. J . Angew. Chem.,
Int. Ed. 2000, 39, 3635-3638. (b) Guerin, D. J .; Miller, S. J . J . Am.
Chem. Soc. 2002, 124, 2134-2136.
(9) Boger, D. L.; Lee, R. J .; Bounaud, P.-Y.; Meier, P. J . Org. Chem.
2000, 65, 6770-6772.
(10) Dudding, T.; Hafez, A. M.; Taggi, A. E.; Wagerle, T. R.; Lectka,
T. Org. Lett. 2002, 4, 387-390.
10.1021/jo034150e CCC: $25.00 © 2003 American Chemical Society
Published on Web 06/21/2003
J . Org. Chem. 2003, 68, 5819-5825
5819